Optimi Health Acquires Extensive Catalog of Psychedelic and Functional Mushroom Genetics
New strains to provide crucial insights in mental health research across the sector May 17, 2022 VANCOUVER, BC — Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), a homegrown, Canadian company producing natural, scalable, and accessible mushroom formulations for transformational human experiences, is pleased to announce... Read more
( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )